MAPT and Alzheimer disease: Sun J. et al. (2019) recently reported that FMT improved cognitive impairment in an APPswe/PS1dE9 transgenic mouse model of AD, accompanied by reduced Aβ deposition in the brain and decreased phosphorylation of tau protein.